| P2093 | author name string | Vittorio Patella | |
| | Valentina Cagnetta | |
| P2860 | cites work | MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR. | Q48199749 |
| | A randomized, double-blind study comparing twenty-four-week treatment with recombinant interferon-gamma versus placebo in the treatment of rheumatoid arthritis | Q49174472 |
| | Alpha1beta1 integrin and interleukin-7 receptor up-regulate the expression of RANKL in human T cells and enhance their osteoclastogenic function. | Q54532999 |
| | T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ | Q59064307 |
| | Role of TNF-alpha producing T-cells in bone loss induced by estrogen deficiency | Q60524719 |
| | Quantitative analysis of cytokine gene expression in rheumatoid arthritis | Q67285954 |
| | Prolonged decrease of serum calcium concentration by murine gamma-interferon in hypercalcemic, human tumor (EC-GI)-bearing nude mice | Q67720743 |
| | Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis | Q69223601 |
| | Comparative study of inhibitory effects by murine interferon ? and a new bisphosphonate (alendronate) in hypercalcemic, nude mice bearing human tumor (LJC-1-JCK) | Q71649346 |
| | Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia | Q72150177 |
| | Activated T lymphocytes support osteoclast formation in vitro | Q73149439 |
| | Immune effects of hormone replacement therapy in post-menopausal women | Q73559562 |
| | Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor | Q81364721 |
| | Immune system and bone metabolism: Does thymectomy influence postmenopausal bone loss in humans? | Q83322481 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells | Q28591227 |
| | Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand | Q29619331 |
| | IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor | Q33268293 |
| | The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. | Q33823576 |
| | CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis | Q33873672 |
| | Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo | Q33950241 |
| | Minireview: the OPG/RANKL/RANK system | Q34102256 |
| | An IL-7-dependent rebound in thymic T cell output contributes to the bone loss induced by estrogen deficiency. | Q34133202 |
| | Signaling crosstalk between RANKL and interferons in osteoclast differentiation | Q34731222 |
| | Increased production of IL-7 uncouples bone formation from bone resorption during estrogen deficiency | Q34816640 |
| | Role of RANK ligand in mediating increased bone resorption in early postmenopausal women | Q34912769 |
| | Transcriptional regulation of the MHC class II antigen presentation pathway | Q35031987 |
| | IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation | Q35219971 |
| | B cells and T cells are critical for the preservation of bone homeostasis and attainment of peak bone mass in vivo | Q35804512 |
| | Estrogen deficiency induces bone loss by increasing T cell proliferation and lifespan through IFN-gamma-induced class II transactivator. | Q35918333 |
| | Dendritic cells at the osteo-immune interface: implications for inflammation-induced bone loss. | Q36757614 |
| | The complex role of estrogens in inflammation. | Q36886660 |
| | Oral mucosal dendritic cells and periodontitis: many sides of the same coin with new twists | Q36938511 |
| | Estrogen deficiency, T cells and bone loss | Q36948752 |
| | T cells: unexpected players in the bone loss induced by estrogen deficiency and in basal bone homeostasis | Q37033722 |
| | Expression of receptor activator of nuclear factor-kappaB ligand by B cells in response to oral bacteria | Q37215919 |
| | Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene | Q37265676 |
| | Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells | Q37531252 |
| | Dendritic cells: a new player in osteoimmunology | Q37622328 |
| | Estrogen prevents bone loss through transforming growth factor beta signaling in T cells | Q37692440 |
| | Molecular analysis of RANKL-independent cell fusion of osteoclast-like cells induced by TNF-alpha, lipopolysaccharide, or peptidoglycan | Q40195873 |
| | 17beta-Estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and cbp recruitment to the class II MHC promoter | Q40555974 |
| | Modulation of gene expression by the MHC class II transactivator | Q40695550 |
| | IL-1 mediates TNF-induced osteoclastogenesis | Q40909592 |
| | Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction | Q41927546 |
| | Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation | Q42475736 |
| | Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: a key mechanism in osteoporosis. | Q42526719 |
| | Immunohistologic assessment of cytokine production of infiltrating cells in various forms of leprosy | Q42774177 |
| P433 | issue | 2 | |
| P921 | main subject | osteoporosis | Q165328 |
| P304 | page(s) | 85-88 | |
| P577 | publication date | 2012-05-01 | |
| P1433 | published in | Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases | Q26842318 |
| P1476 | title | The role of the immune system in the physiopathology of osteoporosis | |
| P478 | volume | 9 | |